IP Library Granted Patent US 7,946,291
Granted Patent B2
US 7,946,291 · App. 10/828,765 · Granted May 24, 2011

Ventilation systems and methods employing aerosol generators

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,946,291
App. No.
10/828,765
Granted
May 24, 2011
Kind
B2
Abstract

A pressure-assisted breathing system comprises a pressure-generating circuit for maintaining a positive pressure within the system, and a patient interface device coupled to a patient's respiratory system. A respiratory circuit is positioned between the pressure-generating circuit and the patient interface device and a nebulizer is coupled to the respiratory circuit.

Claims (11)

1. A method of delivering a surfactant to a patient's respiratory system which comprises the steps of:

providing a CPAP system having a pressure-generating circuit with a first gas flow of sufficiently high volume to maintain continuous positive airway pressure in the system, a respiratory circuit connecting the pressure-generating circuit to a patient interface device, wherein the respiratory circuit contains a second gas flow of lower volume than said first gas flow, and a vibrating aperture nebulizer coupled to the respiratory circuit at a distance from the patient interface device sufficient to provide an acceptable efficiency of delivering a liquid surfactant to the patient's respiratory system;

introducing the liquid surfactant into the nebulizer;

aerosolizing the surfactant in the nebulizer; and

entraining the aerosolized surfactant into the second gas flow of the respiratory circuit to avoid dilution of the aerosolized surfactant delivered to the patient.

2. The method of claim 1 wherein the surfactant is a phospholipid.

3. The method of claim 1 wherein 6-18% of the aerosolized surfactant introduced into the system is delivered to the patient.

4. The method of claim 1 wherein the nebulizer comprises a reservoir having a capacity substantially equal one unit dose of surfactant and substantially all of the contents of the reservoir is delivered to the patient.

5. The method of claim 1 wherein the dose is equal to 10 mg or less of surfactant.

6. The method of claim 1 wherein the patient interface device is selected from the group consisting of nasal prongs, an oral/nasal mask, a nasal mask, nasopharyngeal prongs, a nasopharyngeal tube, a tracheotomy tube, an endotracheal tube and a mouthpiece.

7. The method of claim 6 wherein the patient interface device is an endotracheal tube.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2011
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 026092/0709 →
ASSIGNMENT OF PATENT RIGHTS Recorded Jan 7, 2009
From: AEROGEN, INC.
To: NOVARTIS PHARMA AG
Reel/Frame 022062/0905 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2004
From: FINK, JAMES; IVRI, EHUD
To: AEROGEN, INC.
Reel/Frame 015731/0069 →